As part of a global settlement with numerous attorneys general, including the New York AG, NYDFS also resolved its administrative charges of insurance fraud against pharmaceutical manufacturer Teva over misrepresentations in charges for opioid products.
Notably, Teva had unsuccessfully challenged in New York State court the authority of NYDFS to investigate this conduct as insurance fraud.
The announcement of the NYDFS resolution is here: https://www.dfs.ny.gov/reports_and_publications/press_releases/pr202211031